Davita Healthcare Partners Stock Alpha and Beta Analysis
| DVA Stock | USD 114.72 0.78 0.68% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DaVita HealthCare Partners. It also helps investors analyze the systematic and unsystematic risks associated with investing in DaVita HealthCare over a specified time horizon. Remember, high DaVita HealthCare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DaVita HealthCare's market risk premium analysis include:
Beta 0.8 | Alpha (0.28) | Risk 1.49 | Sharpe Ratio (0.1) | Expected Return (0.15) |
DaVita HealthCare Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out DaVita HealthCare Backtesting, DaVita HealthCare Valuation, DaVita HealthCare Correlation, DaVita HealthCare Hype Analysis, DaVita HealthCare Volatility, DaVita HealthCare History and analyze DaVita HealthCare Performance. DaVita HealthCare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DaVita HealthCare market risk premium is the additional return an investor will receive from holding DaVita HealthCare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DaVita HealthCare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DaVita HealthCare's performance over market.| α | -0.28 | β | 0.80 |
DaVita HealthCare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DaVita HealthCare's Buy-and-hold return. Our buy-and-hold chart shows how DaVita HealthCare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.DaVita HealthCare Market Price Analysis
Market price analysis indicators help investors to evaluate how DaVita HealthCare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DaVita HealthCare shares will generate the highest return on investment. By understating and applying DaVita HealthCare stock market price indicators, traders can identify DaVita HealthCare position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Stalled Pattern | ||
| Separating Lines |
DaVita HealthCare Return and Market Media
The median price of DaVita HealthCare for the period between Thu, Oct 9, 2025 and Wed, Jan 7, 2026 is 120.1 with a coefficient of variation of 4.32. The daily time series for the period is distributed with a sample standard deviation of 5.23, arithmetic mean of 121.1, and mean deviation of 4.38. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 401514 shares by Berkshire Hathaway Inc of DaVita HealthCare at 135.3558 subject to Rule 16b-3 | 10/27/2025 |
2 | INNOCURA Nephrology Announces Affiliation with Kidney Care Centers | 11/03/2025 |
3 | DaVita Inc. to Participate in Fireside Chat with Wolfe Research | 11/14/2025 |
4 | TD Waterhouse Canada Inc. Sells 932 Shares of DaVita Inc. DVA | 11/26/2025 |
5 | Quantbot Technologies LP Increases Stake in DaVita Inc. DVA | 12/03/2025 |
6 | Disposition of 5875 shares by James Hearty of DaVita HealthCare at 108.93 subject to Rule 16b-3 | 12/04/2025 |
7 | Lawmaker asks what happened to federal investigation into predatory for-profit dialysis industry | 12/08/2025 |
8 | Do DaVitas New Strategy and People Chiefs Subtly Recast Its LongTerm Story | 12/12/2025 |
9 | Recent Investment Analysts Ratings Changes for DaVita | 12/16/2025 |
10 | Heres Why You Should Hold DaVita Stock in Your Portfolio for Now | 12/18/2025 |
11 | DaVita HealthCare Beats Stock Market Upswing What Investors Need to Know | 12/22/2025 |
12 | More Than a Meal Plan The Clinical Impact of a Kidney Dietitian | 12/26/2025 |
13 | Caring for Caregivers DaVitas Investment in Nursing Education and Growth | 01/02/2026 |
14 | A Look At DaVita Valuation As Medicare Rules And Value-Based Kidney Care Progress | 01/05/2026 |
About DaVita HealthCare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DaVita or other stocks. Alpha measures the amount that position in DaVita HealthCare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.0136 | 0.0129 | Price To Sales Ratio | 1.14 | 1.71 |
DaVita HealthCare Upcoming Company Events
As portrayed in its financial statements, the presentation of DaVita HealthCare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DaVita HealthCare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DaVita HealthCare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DaVita HealthCare. Please utilize our Beneish M Score to check the likelihood of DaVita HealthCare's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with DaVita HealthCare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out DaVita HealthCare Backtesting, DaVita HealthCare Valuation, DaVita HealthCare Correlation, DaVita HealthCare Hype Analysis, DaVita HealthCare Volatility, DaVita HealthCare History and analyze DaVita HealthCare Performance. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
DaVita HealthCare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.